Yamagata University Hospital

Clinical Divisions

Internal Medicine Ⅲ

Overview of the Neurology Department


　Our department provides medical care for various diseases related to the brain, spinal cord, peripheral nerves, and skeletal muscles.

　In particular:

  1. Stroke
    　Mainly the medical treatment of cerebral infarction.
  2. Dementia
    　Alzheimer's dementia, Lewy body dementia, etc.
  3. Neurodegenerative diseases
    　Parkinson's disease, amyotrophic lateral sclerosis, spinocerebellar degeneration, etc.
  4. Neuroimmune diseases
    　Myasthenia gravis, multiple sclerosis, etc.
  5. Epilepsy
  6. Nerve infections
    　Meningitis, encephalomyelitis, Creutzfeldt-Jakob disease, etc.
  7. Peripheral nerve diseases
    　Guillain-Barre syndrome, chronic inflammatory demyelinating polyneuritis (CIDP), etc.
  8. Muscular diseases
    　Myositis, muscular dystrophy, etc.
  9. Neurofunctional diseases
    　Headache, neuralgia, facial cramps, etc.

*In our hospital, we provide more specialized and advanced medical treatment with doctors who are certified as specialists by the Japanese Society of Neurology, Japanese Society of Stroke, and Japanese Society of Dementia.


Overview of the Diabetes, Metabolism, and Endocrinology Department


　This department provides medical care for diseases related to the metabolism, such as diabetes and dyslipidemia, and various endocrine diseases.

　In particular:

  1. Diabetes mellitus
    　Type 1 diabetes mellitus, type 2 diabetes mellitus, diabetes mellitus caused by other causes, gestational diabetes, etc.
  2. Hypothalamus and pituitary gland disorders
    　Hypopituitarism, acromegaly, prolactin-producing tumors, Cushing's disease, etc.
  3. Thyroid diseases
    　Graves' disease, thyrotoxicosis, hypothyroidism, etc.
  4. Bone metabolism/parathyroid diseases
    　Primary hyperparathyroidism, hypoparathyroidism, osteoporosis, etc.
  5. Adrenal diseases
    　Cushing's syndrome, primary aldosteronism, pheochromocytoma, etc.
  6. Obesity/feeding regulation
    　Primary obesity, inherited obesity, metabolic syndrome, etc.
  7. Lipid metabolism
    　Primary dyslipidemia, secondary dyslipidemia, familial hyperlipidemia, etc.

＊In our hospital, we provide more specialized and advanced medical treatment with doctors who are certified as specialists/instructors by the Japanese Society of Internal Medicine, Japan Diabetes Society, and Japan Endocrine Society.


Overview of the Hematology Department


　This department provide medical care for various diseases related to Hematology.

　In particular:

  1. Chemotherapy and treatment with new drugs for acute leukemia - acute myelogenous leukemia and acute lymphocytic leukemia.
  2. Molecular targeted therapy for chronic myelogenous leukemia and chronic lymphocytic leukemia.
  3. Chemotherapy with antibody therapy (rituximab) for malignant lymphoma.
  4. Chemotherapy with new drugs for plasma cell tumors - multiple myeloma and primary macroglobulinemia.
  5. Treatment with azasididine for myelodysplastic syndrome.
  6. Treatment for chronic myeloproliferative neoplasms - polycythemia vera, essential thrombocythemia, and primary myelofibrosis.
  7. Treatment for erythroid diseases - aplastic anemia, paroxysmal nocturnal hemoglobinuria, autoimmune hemolytic anemia, and iron deficiency anemia.
  8. Treatment for platelet diseases - idiopathic thrombocytopenic purpura and thrombotic thrombocytopenic purpura.
  9. Treatment for blood coagulation disorders - hemophilia and von Willebrand disease.
  10. Autologous peripheral blood stem cell transplantation for malignant lymphoma and multiple myeloma.
  11. Allogeneic hematopoietic cell transplantation for acute leukemia, myelodysplastic syndrome, malignant lymphoma, etc. We are the only certified hospital in Yamagata to provide programs, such as Japanese Merrow Donor Program, Cord Blood Bank, and Japan Society for Hematopoietic Stem Cell Transplantation.

*Our hospital is equipped with the facilities to diagnose and treat all hematological disorders, and we are actively performing the standard treatments as well as using novel drugs and hematopoietic cell transplantation.